A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.
about
An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islandsRisk factors for neoplastic progression in Barrett's esophagusHuman acid ceramidase is overexpressed but not mutated in prostate cancerMolecular regulation of human cathepsin B: implication in pathologiesMolecular biology of Barrett's adenocarcinoma.Expression of cathepsins B and S in the progression of prostate carcinoma.Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.Operomics: molecular analysis of tissues from DNA to RNA to protein.Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI EndoscopyHigh Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaSignificance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.Protease-activated drug development.Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patientsA list of candidate cancer biomarkers for targeted proteomics.Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.Human urine proteomics: building a list of human urine cancer biomarkers.Cathepsin B as a cancer targetCathepsin B: multiple roles in cancer.Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer.Effect of endothelin-1 in esophageal squamous cell carcinoma invasion and its correlation with cathepsin B.Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients.Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis.Transcription of cathepsin B in glioma cells: regulation by an E-box adjacent to the transcription initiation site.Upregulation of cathepsin W-expressing T cells is specific for autoimmune atrophic gastritis compared to other types of chronic gastritis.Cathepsin B: Basis Sequence: Mouse.Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis.
P2860
Q24682438-86AF131E-A6B5-4A68-9DBC-BCBF933BC11CQ27002062-D7A52442-E560-49F8-B1D7-8418892A89CFQ28144553-656118DB-7D67-44F7-AD1C-B7888D501CE1Q28190363-C339150D-3386-4B6C-9DD4-73B5483C2E61Q30327935-F2E1327C-8FA2-4A2C-B104-9B709A400371Q32160033-B150B610-0F0A-40E4-BAD1-C1C1B69E9179Q33918879-1B17C6D8-413B-4F6A-B16B-4FAC792830ABQ34093051-B2A4DF8B-BAC7-4799-8746-FC8F54833B45Q34259612-92D08DD6-C2BF-48FB-B597-E0BF37C1AE95Q35690679-912FC470-3E9A-492C-898E-719616E19D37Q35777627-4BBB7F31-FCD1-448D-BE49-637D328B2D61Q35811508-DA163815-6729-436A-B45D-6421F2AD1FE5Q35842219-D2CC0D45-0AA8-442D-865B-9C3BE3CAF769Q36068428-6041CB90-2522-49B6-9862-559B861F4EB8Q36074431-8B05FFAB-0C40-4A3C-9778-EF39CCD3813FQ36214558-08921A10-3BB7-4458-B9B1-8985792E08ECQ36619772-C5B24FB6-8356-40B6-9295-326FD5C19D71Q37277962-F8F12274-64C2-4FEB-B1AB-393C515AB027Q37599640-FE0BA189-24EA-4789-A143-BED952704AAFQ37890422-7AA37908-EB75-4814-A7EF-5018C83B229DQ38072054-20333503-EE6F-40E3-A548-8BF371D264F7Q38200056-91D37F78-6863-4074-9E74-CF2D38A0A846Q38599774-2D206648-E1E2-41CF-A575-B18D4A057FEAQ39069422-36E2BDBF-BC76-49E8-82C1-0EF6F877803AQ39356134-C4D136D4-B9D2-4DC7-AB79-2510D527AB3CQ40100643-6C258E1D-83C6-4EEA-982F-BC5EB3B9072BQ40162304-3C5F4206-D82C-4FBA-9C88-E46716422ABEQ40598044-67E77454-0FD4-47C7-87C5-0F4746D5EB16Q40608492-6104FCA9-587E-4425-84A7-F7CAC1D348DAQ40820268-EDC4F556-E2D1-499E-A2EC-AB452D53DC4BQ41230243-1AD4E31A-FBB0-4A3A-BFE1-5ACFD907DFABQ44561867-601F2D8B-AE33-4ED9-AA68-1BD34BC69671Q51121654-29DD4F2B-8917-4900-84D4-9C57B0AA0DBA
P2860
A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@ast
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@en
type
label
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@ast
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@en
prefLabel
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@ast
A novel amplicon at 8p22-23 re ...... in esophageal adenocarcinoma.
@en
P2093
P2860
P356
P1476
A novel amplicon at 8p22-23 re ...... B in esophageal adenocarcinoma
@en
P2093
D Thoraval
M B Orringer
S J Hughes
T W Glover
P2860
P304
12410-12415
P356
10.1073/PNAS.95.21.12410
P407
P50
P577
1998-10-01T00:00:00Z